Candel Therapeutics (CADL) Net Cash Flow: 2020-2024
Historic Net Cash Flow for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $67.2 million.
- Candel Therapeutics' Net Cash Flow fell 6.25% to -$7.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.6 million, marking a year-over-year decrease of 171.90%. This contributed to the annual value of $67.2 million for FY2024, which is 294.09% up from last year.
- Per Candel Therapeutics' latest filing, its Net Cash Flow stood at $67.2 million for FY2024, which was up 294.09% from -$34.6 million recorded in FY2023.
- In the past 5 years, Candel Therapeutics' Net Cash Flow registered a high of $67.2 million during FY2024, and its lowest value of -$34.6 million during FY2023.
- For the 3-year period, Candel Therapeutics' Net Cash Flow averaged around $6.6 million, with its median value being -$12.7 million (2022).
- Its Net Cash Flow has fluctuated over the past 5 years, first slumped by 171.90% in 2023, then skyrocketed by 294.09% in 2024.
- Yearly analysis of 5 years shows Candel Therapeutics' Net Cash Flow stood at $29.9 million in 2020, then skyrocketed by 59.83% to $47.7 million in 2021, then slumped by 126.69% to -$12.7 million in 2022, then slumped by 171.90% to -$34.6 million in 2023, then skyrocketed by 294.09% to $67.2 million in 2024.